Centena Biomed Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-12-2024
- Paid Up Capital ₹ 1.00 M
as on 16-12-2024
- Company Age 20 Year, 25 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 16-12-2024
- Satisfied Charges ₹ 1.23 Cr
as on 16-12-2024
- Revenue -4.91%
(FY 2023)
- Profit -92.80%
(FY 2023)
- Ebitda -8.86%
(FY 2023)
- Net Worth 0.22%
(FY 2023)
- Total Assets 16.95%
(FY 2023)
About Centena Biomed
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.00 M. The company has closed loans amounting to ₹1.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dinesh Bajpai, Kiran Trivedi, and Anoop Trivedi serve as directors at the Company.
- CIN/LLPIN
U24232UP2004PTC029264
- Company No.
029264
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Nov 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Centena Biomed Private Limited offer?
Centena Biomed Private Limited offers a wide range of products and services, including Pathology Lab Equipments, Microplate Reader, Rapid Test Kit, Diagnostic Test Kit, Medical Laboratory Instruments, Hematology Analyzers, Medical Consultants & Clinics, Medical Consultancy Services, Scalpels, Needles & Scissors, Retractors.
Who are the key members and board of directors at Centena Biomed?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Bajpai  | Director | 03-Jul-2006 | Current |
| Kiran Trivedi | Director | 29-Nov-2004 | Current |
| Anoop Trivedi | Director | 29-Nov-2004 | Current |
Financial Performance of Centena Biomed.
Centena Biomed Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.91% decrease. The company also saw a substantial fall in profitability, with a 92.8% decrease in profit. The company's net worth moved up by a moderate rise of 0.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Centena Biomed?
In 2023, Centena Biomed had a public holding of 14.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Oct 2023 | ₹4.00 M | Open |
Others Creation Date: 22 Dec 2021 | ₹0.89 M | Satisfied |
Others Creation Date: 29 Jul 2020 | ₹1.10 M | Satisfied |
How Many Employees Work at Centena Biomed?
Unlock and access historical data on people associated with Centena Biomed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Centena Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centena Biomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
